OCGN — Ocugen Income Statement
0.000.00%
Last trade - 00:00
- $329.38m
- $292.71m
- $6.04m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.043 | 0 | 2.49 | 6.04 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 14.5 | 21.3 | 57.6 | 91.6 | 71.6 |
Operating Profit | -14.5 | -21.3 | -57.6 | -89.1 | -65.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -20.2 | -21.8 | -58.4 | -86.8 | -63.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -20.2 | -21.8 | -58.4 | -86.8 | -63.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -20.2 | -21.8 | -58.4 | -86.8 | -63.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -20.2 | -34.4 | -58.4 | -86.8 | -63.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.43 | -0.306 | -0.301 | -0.404 | -0.258 |